Perfusia Biosciences Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Perfusia Biosciences General Information


Developer of a medical technology platform designed to offer pharmaceutical drug testing. The company's platform allows for implantation and vascular support of various tissues within a microfluidic platform to be used to model a wide range of organs and diseases from brain cancer to drug absorption in the gut, providing hospitals with stem cell-derived vitro disease 3D organ models for assistance in drug discovery.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 100 College Street
  • Room 156
  • Toronto, Ontario M5G 1L5
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perfusia Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 14-Jun-2022 Completed Out of Business
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Perfusia Biosciences’s complete valuation and funding history, request access »